Opioid-use Disorder Clinical Trials

21 recruiting

Opioid-use Disorder Trials at a Glance

22 actively recruiting trials for opioid-use disorder are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in New York, Philadelphia, and Baltimore. Lead sponsors running opioid-use disorder studies include New York State Psychiatric Institute, Yale University, and Brown University.

Browse opioid-use disorder trials by phase

Treatments under study

About Opioid-use Disorder Clinical Trials

Looking for clinical trials for Opioid-use Disorder? There are currently 21 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Opioid-use Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Opioid-use Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 22 trials

Recruiting

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Healthy ControlSchizophreniaPost Traumatic Stress Disorder+4 more
Yale University100 enrolled1 locationNCT01730781
Recruiting

Systematic Examination of Health Inequalities: Documentation, Patterns, and Determinants

IncarcerationNon-communicable Diseases (NCD)Addiction to Opioids+1 more
University of Thessaly2,000 enrolled5 locationsNCT07558187
Recruiting
Phase 1Phase 2

Clinical Trials of Multivalent Opioid Vaccine Components

Opioid-use Disorder
New York State Psychiatric Institute45 enrolled2 locationsNCT04458545
Recruiting
Not Applicable

Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment

Chronic PainOpioid-use Disorder
Albert Einstein College of Medicine123 enrolled1 locationNCT05039554
Recruiting
Not Applicable

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)

Substance Use DisordersOpioid-use Disorder
InSightec29 enrolled4 locationsNCT04197921
Recruiting
Not Applicable

Optimization of NIBS for Treatment of Addiction

Chronic PainOpioid-use Disorder
Case Western Reserve University126 enrolled3 locationsNCT04379115
Recruiting
Phase 3

Smartphones for Opiate Addiction Recovery

Opioid-use Disorder
NYU Langone Health225 enrolled2 locationsNCT05033028
Recruiting
Not Applicable

Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

Opioid UseOpioid-use DisorderSubstance Use+2 more
Wake Forest University Health Sciences600 enrolled2 locationsNCT04927143
Recruiting
Not Applicable

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

Opioid-use Disorder
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)3 enrolled1 locationNCT04354077
Recruiting

Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes

Opioid-use DisorderOpioid Use, UnspecifiedBuprenorphine Dependence
Senthil Sadhasivam600 enrolled1 locationNCT03923374
Recruiting
Phase 4

Young Houston Emergency Opioid Engagement System

Opioid UseSubstance Use DisordersOpioid-use Disorder+2 more
The University of Texas Health Science Center, Houston250 enrolled1 locationNCT04811014
Recruiting
Not Applicable

The Youth Opioid Recovery Support (YORS) Intervention

Opioid-use DisorderMedication Adherence
Potomac Health Foundations150 enrolled1 locationNCT04173416
Recruiting
Not Applicable

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

Substance Use DisordersOpioid-use DisorderHepatitis C+1 more
Columbia University418 enrolled1 locationNCT03135886
Recruiting
Not Applicable

Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services

Opioid-use DisorderHIV Prevention Program
Yale University526 enrolled6 locationsNCT04738825
Recruiting
Not Applicable

Neuromodulation and Cognitive Training in Opioid Use Disorder

Opioid-use DisorderOpioid DependenceOpioid Abuse
University of Minnesota30 enrolled1 locationNCT03773523
Recruiting
Phase 2Phase 3

Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments

Opioid-use Disorder
University of British Columbia658 enrolled6 locationsNCT04893525
Recruiting
Phase 2

Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans

Post Traumatic Stress DisorderOpioid-use Disorder
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance120 enrolled2 locationsNCT04360681
Recruiting
Not Applicable

Opioid Treatment and Peer Recovery Support

Opioid-use Disorder
Brown University450 enrolled3 locationsNCT04978168
Recruiting
Phase 2Phase 3

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

Opioid-use Disorder
New York State Psychiatric Institute180 enrolled2 locationsNCT05011266
Recruiting
Phase 2

Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

InflammationHIV-1-infectionOpioid-use Disorder+5 more
University of Pennsylvania225 enrolled2 locationsNCT04480554